Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Peritoneal surface disease from colorectal cancer: comparison with the hepatic metastases surgical paradigm in optimally resected patients.

Shen P, Thai K, Stewart JH, Howerton R, Loggie BW, Russell GB, Levine EA.

Ann Surg Oncol. 2008 Dec;15(12):3422-32. doi: 10.1245/s10434-008-0127-4. Epub 2008 Sep 11.

PMID:
18784963
2.

Metastatic colorectal cancer: survival comparison of hepatic resection versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Blackham AU, Russell GB, Stewart JH 4th, Votanopoulos K, Levine EA, Shen P.

Ann Surg Oncol. 2014 Aug;21(8):2667-74. doi: 10.1245/s10434-014-3563-3. Epub 2014 Mar 11.

3.
4.

Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma.

Shen P, Hawksworth J, Lovato J, Loggie BW, Geisinger KR, Fleming RA, Levine EA.

Ann Surg Oncol. 2004 Feb;11(2):178-86.

PMID:
14761921
5.

Peritoneal surface disease with synchronous hepatic involvement treated with Cytoreductive Surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

Randle RW, Doud AN, Levine EA, Clark CJ, Swett KR, Shen P, Stewart JH, Votanopoulos KI.

Ann Surg Oncol. 2015 May;22(5):1634-8. doi: 10.1245/s10434-014-3987-9. Epub 2014 Aug 14.

6.

Peritoneal carcinomatosis with synchronous liver metastases from colorectal cancer: Who will benefit from complete cytoreductive surgery?

Delhorme JB, Dupont-Kazma L, Addeo P, Lefebvre F, Triki E, Romain B, Meyer N, Bachellier P, Rohr S, Brigand C.

Int J Surg. 2016 Jan;25:98-105. doi: 10.1016/j.ijsu.2015.11.025. Epub 2015 Dec 1.

PMID:
26607853
7.

Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies.

de Cuba EM, Kwakman R, Knol DL, Bonjer HJ, Meijer GA, Te Velde EA.

Cancer Treat Rev. 2013 Jun;39(4):321-7. doi: 10.1016/j.ctrv.2012.11.003. Epub 2012 Dec 12. Review.

PMID:
23244778
8.

Outcomes following surgery for colorectal cancer with synchronous peritoneal metastases.

Mulsow J, Merkel S, Agaimy A, Hohenberger W.

Br J Surg. 2011 Dec;98(12):1785-91. doi: 10.1002/bjs.7653. Epub 2011 Aug 26.

PMID:
22034185
9.

Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures.

Levine EA, Stewart JH 4th, Russell GB, Geisinger KR, Loggie BL, Shen P.

J Am Coll Surg. 2007 May;204(5):943-53; discussion 953-5. Erratum in: J Am Coll Surg. 2007 Oct;205(4):630.

PMID:
17481516
10.

Comparison of optimally resected hepatectomy and peritonectomy patients with colorectal cancer metastasis.

Cao CQ, Yan TD, Liauw W, Morris DL.

J Surg Oncol. 2009 Dec 1;100(7):529-33. doi: 10.1002/jso.21369.

PMID:
19697395
11.

Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients.

Baratti D, Kusamura S, Iusco D, Bonomi S, Grassi A, Virzì S, Leo E, Deraco M.

Dis Colon Rectum. 2014 Jul;57(7):858-68. doi: 10.1097/DCR.0000000000000149.

PMID:
24901687
12.

Pilot study of adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at high risk for the development of peritoneal metastases.

Virzì S, Iusco D, Baratti D, Bonomi S, Grassi A, Kusamura S, Deraco M.

Tumori. 2013 Sep-Oct;99(5):589-95. doi: 10.1700/1377.15307.

PMID:
24362862
13.

Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.

Allard MA, Adam R, Ruiz A, Vibert E, Paule B, Levi F, Sebagh M, Guettier C, Azoulay D, Castaing D.

Eur J Surg Oncol. 2013 Sep;39(9):981-7. doi: 10.1016/j.ejso.2013.06.009. Epub 2013 Jul 8.

PMID:
23845705
14.

Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy.

Kornprat P, Jarnagin WR, Gonen M, DeMatteo RP, Fong Y, Blumgart LH, D'Angelica M.

Ann Surg Oncol. 2007 Mar;14(3):1151-60. Epub 2006 Dec 31.

PMID:
17195913
15.

Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy.

Andreou A, Aloia TA, Brouquet A, Dickson PV, Zimmitti G, Maru DM, Kopetz S, Loyer EM, Curley SA, Abdalla EK, Vauthey JN.

Ann Surg. 2013 Jun;257(6):1079-88. doi: 10.1097/SLA.0b013e318283a4d1.

16.

Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival.

Heslin MJ, Medina-Franco H, Parker M, Vickers SM, Aldrete J, Urist MM.

Arch Surg. 2001 Mar;136(3):318-23. Erratum in: Arch Surg 2001 Jul;136(7):809.

PMID:
11231853
17.

Peritoneal surface disease (PSD) from appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): overview of 481 cases.

Votanopoulos KI, Russell G, Randle RW, Shen P, Stewart JH, Levine EA.

Ann Surg Oncol. 2015 Apr;22(4):1274-9. doi: 10.1245/s10434-014-4147-y. Epub 2014 Oct 16.

18.

R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?

de Haas RJ, Wicherts DA, Flores E, Azoulay D, Castaing D, Adam R.

Ann Surg. 2008 Oct;248(4):626-37. doi: 10.1097/SLA.0b013e31818a07f1.

PMID:
18936576
19.

[Specific treatment situations in metastatic colorectal cancer].

Arnold D, Schmoll HJ, Lang H, Knoefel WT, Ridwelski K, Trarbach T, Staib L, Kirchner T, Geissler M, Seufferlein T, Amthauer H, Riess H, Schlitt HJ, Piso P.

Onkologie. 2010;33 Suppl 4:8-18. doi: 10.1159/000308447. Epub 2010 Apr 23. Review. German.

PMID:
20431307
20.

Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with peritoneal hepatocellular carcinoma.

Tabrizian P, Franssen B, Jibara G, Sweeney R, Sarpel U, Schwartz M, Labow D.

J Surg Oncol. 2014 Dec;110(7):786-90. doi: 10.1002/jso.23739. Epub 2014 Aug 5.

PMID:
25091997

Supplemental Content

Support Center